Ennis & Ennis, P.A. Investigates Possible Lawsuit With Merck Over Fosamax Side Effects

16 April 2006

In an interview with WUSA news in Washington D.C. Attorney David F. Ennis of Ennis & Ennis, P.A. spoke candidly about the need for drug makers to warn patients of serious and sometimes life threatening side effects. Attorney David Ennis spoke of the potential for Fosamax to do damage to the jaw bone (osteonecrosis of the jaw) and the lack of a clearly stated warning in the patient prescribing information. Mr. Ennis also stated that as public awareness of Fosamax causing osteonecrosis of the jaw has grown he has noticed an increase in inquiries regarding lawsuits against the makers of Fosamax, Merck. The full interview with Attorney David F. Ennis regarding Fosamax lawsuits can be read below:

Drug To Strengthen Bones Could Do The Opposite

It's meant to keep your bones strong, but a new class action lawsuit claims the popular drug Fosamax may do just the opposite. Some patients claim long-term use of the drug can rot your jaw. Some have even lost their jaws completely.

It could potentially be the latest in legal trouble for the drug company Merck, which is still reeling from the Vioxx scandal.

Fosamax is meant to prevent osteoporosis, or thinning of the bones, but it may actually be doing just the opposite.

Michael Schwartz, an oral surgeon in Baltimore says most doctors aren't even aware of the problems Fosamax can cause. It belongs to a class of drugs called bisphosphonates, which also include the pills Actonel and Boniva and the IV drugs Aredia and Zometa, which are typically used in cancer patients.

Sheldon Gottesfeld has an area of his jaw that's literally dead. It's called osteonecrosis of the jaw and after 11 years after being successfully treated for leukemia, Sheldon's losing his teeth.

Not from cancer, but his doctor believe from taking Fosamax and Zometa as a preventative measure.

For patients like Sheldon, a simple tooth extraction can shatter the jaw. Reconstructive surgery can be disfiguring and may not heal. Sheldon is worried; he might need two teeth pulled.

DC Attorney David Ennis has an alert sent to doctors by drug maker Novartis, which says patients and doctors are not adequately warned about the risk of dead jaw.

"We (Merck) certainly encourage any patient taking Fosamax to tell their dentist before any procedure," company spokesman Christopher Loder said.

He also said that Merck added the warning to its U.S. labels at the request of the FDA. That label is actually a 22-page document which is given to pharmacies that dispense Fosamax. The item on osteonecrosis of the jaw is buried in the middle of page 13.

Sheldon says he never saw any warning on his drug labels.

Ennis, the attorney, says: "It's a $3 billion dollar a year drug. This company clearly is putting profit over people...because it knows once it puts a black box warning on label, sales will go down."

Sheldon stopped taking Fosamax and Zometa, but doctors say they can stay in the body for up to 10 years. So the worst may not be over.

Drugs like Fosamax are effective against osteoporosis, so for now no one is suggesting you stop taking them. Complications like dead jaw are considered rare, but, expect to hear more about the problem as doctors and patients become more aware of this condition, as well as a class action lawsuit.

For more information regarding Fosamax side effects or to reach the Fosamax lawyers of Ennis & Ennis, P.A. regarding a Fosamax lawsuit call toll-free: 1-800-856-6405 or visit: http://www.fosamax-lawyer.com.

Source: theopenpress

All trademarks and copyrighted information contained herein are the property of their respective owners.